...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Arthritis research & therapy. >Does moderate-to-high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial.
【24h】

Does moderate-to-high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial.

机译：中高强度的北欧式行走是否能改善纤维肌痛的功能和疼痛？前瞻性随机对照试验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

INTRODUCTION: The objective of this study was to investigate the effects of moderate-to-high intensity Nordic walking (NW) on functional capacity and pain in fibromyalgia (FM). METHODS: A total of 67 women with FM were recruited to the study and randomized either to moderate-to-high intensity Nordic Walking (n = 34, age 48 +/- 7.8 years) or to a control group engaging in supervised low-intensity walking (LIW, n = 33, age 50 +/- 7.6 years). Primary outcomes were the six-minute walk test (6MWT) and the Fibromyalgia Impact Questionnaire Pain scale (FIQ Pain). Secondary outcomes were: exercise heart rate in a submaximal ergometer bicycle test, the FIQ Physical (activity limitations) and the FIQ total score. RESULTS: A total of 58 patients completed the post-test. Significantly greater improvement in the 6MWT was found in the NW group (P = 0.009), as compared with the LIW group. No between-group difference was found for the FIQ Pain (P = 0.626). A significantly larger decrease in exercise heart rate (P = 0.020) and significantly improved scores on the FIQ Physical (P = 0.027) were found in the NW group as compared with the LIW group. No between-group difference was found for the change in the FIQ total. The effect sizes were moderate for the above mentioned outcomes. CONCLUSIONS: Moderate-to-high intensity aerobic exercise by means of Nordic walking twice a week for 15 weeks was found to be a feasible mode of exercise, resulting in improved functional capacity and a decreased level of activity limitations. Pain severity did not change over time during the exercise period. TRIAL REGISTRATION : Clinicaltrials.gov identifier NCT00643006.
机译：简介：本研究的目的是研究中度至高强度的北欧行走（NW）对纤维肌痛（FM）的功能和疼痛的影响。方法：共有67名FM女性入选本研究，随机分为中度至高强度北欧式行走（n = 34，年龄48 +/- 7.8岁）或对照组，进行有监督的低强度运动步行（LIW，n = 33，年龄50 +/- 7.6岁）。主要结果是六分钟步行测试（6MWT）和纤维肌痛影响问卷疼痛量表（FIQ疼痛）。次要结果为：次最大测功自行车测试中的运动心率，FIQ身体状况（活动限制）和FIQ总分。结果：共58例患者完成了测试后。与LIW组相比，NW组在6MWT方面有显着改善（P = 0.009）。 FIQ疼痛未发现组间差异（P = 0.626）。与LIW组相比，NW组的运动心率降低幅度更大（P = 0.020），FIQ Physical得分显着提高（P = 0.027）。 FIQ总计的变化未发现组间差异。对于上述结果，效果大小适中。结论：通过北欧健走每周两次，持续15周，进行中度至高强度的有氧运动是一种可行的运动方式，从而提高了功能能力并降低了活动极限水平。在运动期间，疼痛的严重程度没有随时间变化。试验注册：Clinicaltrials.gov标识符NCT00643006。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号